{"log_id": 4677403286473904472, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 4e-06, "average": 0.998682, "min": 0.9946}, "location": {"width": 115, "top": 221, "height": 29, "left": 207}, "words": "【临床研究】"}, {"probability": {"variance": 1e-06, "average": 0.998837, "min": 0.997584}, "location": {"width": 66, "top": 257, "height": 26, "left": 198}, "words": "成年人"}, {"probability": {"variance": 1e-06, "average": 0.99901, "min": 0.996626}, "location": {"width": 151, "top": 291, "height": 26, "left": 198}, "words": "院内获得性肺炎"}, {"probability": {"variance": 1e-06, "average": 0.999404, "min": 0.996591}, "location": {"width": 812, "top": 325, "height": 34, "left": 239}, "words": "有临床和放射学证实的院内获得性肺炎的成年患者入选至一个随机、多中心、双盲的研"}, {"probability": {"variance": 0.002984, "average": 0.986911, "min": 0.63726}, "location": {"width": 854, "top": 358, "height": 36, "left": 197}, "words": "究中。患者治疗7-21天。一组患者应用利奈唑胺静脉注射600mg每12小时一次,另一组给"}, {"probability": {"variance": 0.00097, "average": 0.991663, "min": 0.802185}, "location": {"width": 858, "top": 390, "height": 38, "left": 197}, "words": "予万古霉素静脉注射1g每12小时一次。二组均接受氨曲南(1至2克每8小时静脉注射一次)"}, {"probability": {"variance": 7.7e-05, "average": 0.996524, "min": 0.958427}, "location": {"width": 855, "top": 426, "height": 34, "left": 196}, "words": "合并用药,若有临床指征,氨曲南的疗程可以延长。203例患者入选利奈唑胺治疗组,193例"}, {"probability": {"variance": 0.00024, "average": 0.99313, "min": 0.923425}, "location": {"width": 858, "top": 457, "height": 36, "left": 192}, "words": "患者入选万古霉素治疗组。122(60%)例利奈唑胺治疗组患者和103(53%)例万古霉素治"}, {"probability": {"variance": 9e-06, "average": 0.99876, "min": 0.981111}, "location": {"width": 858, "top": 491, "height": 35, "left": 192}, "words": "疗组患者可进行临床评价。利奈唑胺治疗组临床可评价患者中的治愈率为57%,万古霉素治"}, {"probability": {"variance": 2e-06, "average": 0.999273, "min": 0.994902}, "location": {"width": 842, "top": 524, "height": 34, "left": 191}, "words": "疗组为60%。呼吸机相关肺炎的临床可评价患者中,利奈唑胺治疗组患者的治愈率为47%"}, {"probability": {"variance": 1.5e-05, "average": 0.998581, "min": 0.974797}, "location": {"width": 857, "top": 558, "height": 33, "left": 193}, "words": "万古霉素治疗组为40%。调整的意向治疗(MITT)患者中,利奈唑胺治疗组有94例,万古"}, {"probability": {"variance": 0.000388, "average": 0.995349, "min": 0.874462}, "location": {"width": 860, "top": 590, "height": 34, "left": 191}, "words": "霉素治疗组患者有83例,包括治疗前已分离出致病菌株的患者。MITT分析利奈唑胺治疗组"}, {"probability": {"variance": 2e-06, "average": 0.99897, "min": 0.993538}, "location": {"width": 858, "top": 623, "height": 34, "left": 191}, "words": "病人的治愈率为57%,万古霉素治疗组为46%。对微生物学可评估患者不同病原体的治愈率"}, {"probability": {"variance": 0.006208, "average": 0.941574, "min": 0.807803}, "location": {"width": 66, "top": 656, "height": 25, "left": 190}, "words": "见表11"}, {"probability": {"variance": 0.000131, "average": 0.995606, "min": 0.936354}, "location": {"width": 736, "top": 688, "height": 36, "left": 251}, "words": "表11微生物学可评估的院内获得性肺炎的成年患者治愈检测随访时的治愈率"}, {"probability": {"variance": 0, "average": 0.999705, "min": 0.999547}, "location": {"width": 66, "top": 734, "height": 19, "left": 713}, "words": "治愈"}, {"probability": {"variance": 3e-06, "average": 0.998568, "min": 0.996293}, "location": {"width": 58, "top": 747, "height": 24, "left": 288}, "words": "病原体"}, {"probability": {"variance": 0.000256, "average": 0.988262, "min": 0.950854}, "location": {"width": 107, "top": 768, "height": 23, "left": 534}, "words": "利奈唑胺n/N"}, {"probability": {"variance": 0.012603, "average": 0.950446, "min": 0.618715}, "location": {"width": 141, "top": 770, "height": 23, "left": 830}, "words": "万古霉素n/N(%)"}, {"probability": {"variance": 7e-06, "average": 0.998318, "min": 0.992128}, "location": {"width": 127, "top": 804, "height": 20, "left": 199}, "words": "金黄色葡萄球菌"}, {"probability": {"variance": 0.002334, "average": 0.966038, "min": 0.870639}, "location": {"width": 44, "top": 810, "height": 17, "left": 594}, "words": "8(61)"}, {"probability": {"variance": 7e-06, "average": 0.997989, "min": 0.991624}, "location": {"width": 222, "top": 836, "height": 22, "left": 195}, "words": "耐甲氧西林金黄色葡萄球菌"}, {"probability": {"variance": 0.000129, "average": 0.986845, "min": 0.975465}, "location": {"width": 17, "top": 844, "height": 18, "left": 869}, "words": "7/"}, {"probability": {"variance": 0, "average": 0.999785, "min": 0.999257}, "location": {"width": 94, "top": 869, "height": 21, "left": 196}, "words": "肺炎链球菌"}, {"probability": {"variance": 5e-06, "average": 0.997965, "min": 0.991412}, "location": {"width": 283, "top": 968, "height": 29, "left": 183}, "words": "复杂性皮肤和皮肤软组织感染"}, {"probability": {"variance": 1e-06, "average": 0.999547, "min": 0.99618}, "location": {"width": 823, "top": 1001, "height": 33, "left": 225}, "words": "患复杂性皮肤和皮肤软组织感染的成年患者入选至一个随机、多中心、双盲、双模拟的"}, {"probability": {"variance": 3e-06, "average": 0.999061, "min": 0.99189}, "location": {"width": 848, "top": 1033, "height": 33, "left": 180}, "words": "研究中,比较试验药物静脉给药后转为口服给药,总疗程10至21天的药物疗效和安全性"}, {"probability": {"variance": 4.2e-05, "average": 0.996955, "min": 0.96064}, "location": {"width": 849, "top": 1065, "height": 35, "left": 199}, "words": "组患者利奈唑胺静脉给药600mg每12小时一次,然后转成利奈唑胺口服600mg片剂每12"}, {"probability": {"variance": 5e-06, "average": 0.998713, "min": 0.989934}, "location": {"width": 870, "top": 1097, "height": 36, "left": 179}, "words": "小时一次;另一组苯唑西林静脉给药2g每6小时一次,然后转为双氯西林口服500mg每6"}, {"probability": {"variance": 4.6e-05, "average": 0.997689, "min": 0.957661}, "location": {"width": 871, "top": 1130, "height": 34, "left": 179}, "words": "小时一次。若有临床指征,患者可同时给予氨曲南。入选此研究的患者,利奈唑胺治疗组有"}, {"probability": {"variance": 6e-06, "average": 0.998009, "min": 0.988427}, "location": {"width": 868, "top": 1163, "height": 33, "left": 180}, "words": "400例,苯唑西林治疗组有419例。利奈唑胺治疗组有245例患者(61%),苯唑西林组242"}, {"probability": {"variance": 4e-06, "average": 0.998763, "min": 0.991916}, "location": {"width": 873, "top": 1196, "height": 33, "left": 175}, "words": "例患者(58%)可进行临床评估。利奈唑胺治疗组临床可评估患者治愈率为90%,苯唑西林"}, {"probability": {"variance": 0.00061, "average": 0.994644, "min": 0.838872}, "location": {"width": 873, "top": 1229, "height": 33, "left": 174}, "words": "组为85%。调整的意向治疗(MTT)分析包括那些符合入选标准的受试者,利奈唑胺治疗组"}, {"probability": {"variance": 9.2e-05, "average": 0.996451, "min": 0.943425}, "location": {"width": 871, "top": 1261, "height": 34, "left": 176}, "words": "有316例,苯唑西林组有313例。利奈唑胺治疗组患者MITT分析治愈率为86%,苯唑西林"}, {"probability": {"variance": 0.00031, "average": 0.995226, "min": 0.899528}, "location": {"width": 658, "top": 1296, "height": 28, "left": 174}, "words": "治疗组为82%。对微生物学可评估的患者不同病原体的治愈率见表13"}, {"probability": {"variance": 2.3e-05, "average": 0.996692, "min": 0.979777}, "location": {"width": 801, "top": 1372, "height": 33, "left": 170}, "words": "表13复杂性皮肤和皮肤软组织感染微生物学可评估患者治愈检测随访时的治愈率"}, {"probability": {"variance": 6e-06, "average": 0.99782, "min": 0.994443}, "location": {"width": 62, "top": 1413, "height": 23, "left": 284}, "words": "病原体"}, {"probability": {"variance": 4e-06, "average": 0.996592, "min": 0.994512}, "location": {"width": 79, "top": 1416, "height": 22, "left": 707}, "words": "治愈"}, {"probability": {"variance": 0.000369, "average": 0.985179, "min": 0.941942}, "location": {"width": 115, "top": 1451, "height": 24, "left": 531}, "words": "利奈唑胺n/N"}, {"probability": {"variance": 0.021404, "average": 0.935633, "min": 0.525497}, "location": {"width": 156, "top": 1454, "height": 23, "left": 779}, "words": "苯唑西林/双氯西林"}, {"probability": {"variance": 1e-06, "average": 0.998904, "min": 0.997465}, "location": {"width": 133, "top": 1486, "height": 24, "left": 179}, "words": "金黄色葡萄球菌"}, {"probability": {"variance": 0.000944, "average": 0.972397, "min": 0.913351}, "location": {"width": 40, "top": 1495, "height": 18, "left": 854}, "words": "72/84"}, {"probability": {"variance": 9.3e-05, "average": 0.995034, "min": 0.968971}, "location": {"width": 224, "top": 1522, "height": 23, "left": 179}, "words": "耐甲氧西林金黄色葡萄球菌"}, {"probability": {"variance": 0, "average": 0.997358, "min": 0.996897}, "location": {"width": 16, "top": 1528, "height": 17, "left": 575}, "words": "2/"}, {"probability": {"variance": 2e-06, "average": 0.998652, "min": 0.995858}, "location": {"width": 91, "top": 1557, "height": 21, "left": 180}, "words": "无乳链球菌"}, {"probability": {"variance": 4.3e-05, "average": 0.996137, "min": 0.983147}, "location": {"width": 93, "top": 1591, "height": 19, "left": 176}, "words": "化脓链球菌"}, {"probability": {"variance": 0.001399, "average": 0.967079, "min": 0.892668}, "location": {"width": 68, "top": 1594, "height": 22, "left": 854}, "words": "2/28(75"}, {"probability": {"variance": 1e-06, "average": 0.998754, "min": 0.996604}, "location": {"width": 147, "top": 1635, "height": 20, "left": 529}, "words": "第19页,共29页"}, {"probability": {"variance": 0.009015, "average": 0.898488, "min": 0.792707}, "location": {"width": 109, "top": 1660, "height": 19, "left": 546}, "words": "辉瑞——机密"}, {"probability": {"variance": 0.000357, "average": 0.987336, "min": 0.939478}, "location": {"width": 74, "top": 1680, "height": 20, "left": 257}, "words": "20160525"}], "language": 3}